- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
-
Your selected country is
United States
- Change country/language
-
Promotions
-
sk-testpage
-
BD Primer Program
-
BD Discovery 2021
-
Reagents
-
DO NOT PUBLISH
-
Reagentes Com Valor Promocional
-
Lunch Box Giveaway
-
EQCプログラム 外部精度管理 施設間精度管理
-
Backbone Reagents Promo
-
Backbone Reagents Promo
-
Classic Dyes
-
Back to Lab
-
End of Year
-
Tcell Backbone Panel Promotion
-
BD Horizon™ Human T Cell Backbone Panel
-
New Lab Promotion
-
Flash Sale
-
BD Panel Design Program
-
Real Dyes Sample Offer
-
BD’s 50 Years of Innovation Research Instrument Promotion
-
BD FACSLyric™ Flow Cytometers 50th Anniversary Promo
-
BD FACSAria™ Customer Loyalty Promotion
-
FlowJo™ Software Promotion
-
BD® Research Cloud Promotion
-
sk-testpage
-
Custom BD® AbSeq
-
Custom AbSeq FAQ Answer 2
-
Custom AbSeq FAQ Answer 3
-
Custom AbSeq FAQ Answer 4
-
Custom AbSeq FAQ Answer 5
-
Custom AbSeq FAQ Answer 6
-
Custom AbSeq FAQ Answer 7
-
Custom AbSeq FAQ Answer 8
-
Custom AbSeq FAQ Answer 9
-
Custom AbSeq FAQ Answer 10
-
Custom AbSeq FAQ Answer 11
-
Custom AbSeq FAQ Answer 12
-
Custom AbSeq FAQ Answer 13
-
Custom AbSeq FAQ Answer 14
-
Custom AbSeq FAQ Answer 15
-
Custom AbSeq FAQ Answer 16
-
Custom AbSeq FAQ Answer 17
-
Custom AbSeq FAQ Answer 18
-
Custom AbSeq FAQ Answer 19
-
Custom AbSeq FAQ Answer 20
-
Custom AbSeq FAQ Answer 2
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- Change country/language
Old Browser
Your account has been put on hold due to inactivity. To re-activate, check your account information and make all necessary updates.
Looks like you're visiting us from {{countryName}}.
Would you like to remain on the current country site or be redirected to one based on your location?
live copy GB
Your account has been put on hold due to inactivity. To re-activate, check your account information and make all necessary updates.
Depolarised Mitochondria in CD8+ TILs Induce T-Cell Exhaustion
Impact of Mitochondria in CD8+ TILs on Metabolism1
The anti-tumour activity of tumour-infiltrating T lymphocytes (TILs) can be attenuated by metabolic challenges present in tumours. The tumour microenvironment (TME) is home to many factors that impose restrictions on the anti-tumour activities of TILs by interfering with their metabolic pathways and transcriptional and translational regulations2.
It is not clearly understood how TILs adapt to these sustained metabolic challenges imposed by the TME and whether any inability to adapt can result in T-cell dysfunction or exhaustion.
Mitochondria play a key role in sustaining the metabolic fitness of cells in response to metabolic perturbations by increased mitochondrial fusion and biogenesis. Mitochondria that are damaged during this process are cleared from the cell by mitophagy.
Non-clearance of damaged mitochondria results in an increased accumulation of mitochondrial mass with reduced membrane potential (depolarised mitochondria) and the prevention of mitochondrial biogenesis through reprogramming of the epigenome and transcriptome.
Mitochondrial dynamics have also been suggested to modulate the generation of memory CD8+ cells. Furthermore, decreased mitochondrial biogenesis and production of reactive oxygen species (ROS) can promote T cell dysfunction in chronic viral infections and tumours3–5.
Comparing Two CD8+ TIL Subsets
In their paper “Disturbed mitochondrial dynamics in CD8(+) TILs reinforce T cell exhaustion,” published in Nature Immunology, Yu, et.al investigated how T cell anti-tumour responses may be influenced by mitochondrial dynamics and quality.
By flow cytometry analysis of cluster of differentiation 8 tumour-infiltrating T lymphocytes (CD8+ TILs) from spleens, draining lymph nodes and tumours from melanoma-engrafted mice, the authors propose that CD8+ T cells in the TME are prone to accumulating mitochondria with compromised mitochondrial membrane potentials.
They propose that CD8+ TILs contain two subsets with distinct mitochondrial morphologies – one with normal and the other with impaired mitophagy activity. The authors opine that the disruption of mitophagy activity further enhances the mitochondrial depolarisation phenotype in CD8+ TILs.
Furthermore, comparing the two subsets of CD8+ TILs using gene set enrichment analysis (GSEA), the authors observe that the CD8+ T-cell subset with disrupted mitophagy activity is enriched in gene signatures of exhausted CD8+ T cells.
According to the authors, these cells also undergo less population expansion, express higher amounts of programmed cell death protein 1 (PD-1) and LAG-3, and produce less IFN-γ, suggestive of terminal T-cell exhaustion.
These results enable the authors to suggest that the accumulation of depolarised mitochondria in CD8+ TILs propels T cells towards terminal exhaustion and locks them in a permanent dysfunctional state.
How mitochondrial dynamics facilitate the anti-tumour response of CD8+ TILs
The experiments have also allowed the authors to establish a link between depolarised mitochondria and exhaustion epigenetic programs.
Looking at differential chromatin accessibility of the two CD8+ TIL subsets, the authors could propose that the subset with depolarised mitochondria is more exhausted and less memory-like compared to the subset with normal mitochondria.
Finally, the authors also observe that T-cell receptor (TCR) and PD-1 stimulation in the TME can drive the accumulation of depolarised mitochondria. They observe that TCR stimulation coordinates with metabolic stress to suppress mitophagy and thereby maximise the formation of the CD8+ TIL subset with depolarised mitochondria.
All the results put together have enabled the authors to derive more information into how mitochondrial dynamics and quality orchestrate CD8+ T cell anti-tumour responses and reinforce T-cell exhaustion.
Read more scientific publications
References
- Yu YR, Imrichova H, Wang H, et al. Disturbed mitochondrial dynamics in CD8(+) TILs reinforce T cell exhaustion. Nat Immunol. 2020;21(12):1540-1551. doi:10.1038/s41590-020-0793-3
- Li X, Wenes M, Romero P, Huang SCC, Fendt SM, Ho PC. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat Rev Clin Oncol. 2019;16(7):425-441. doi:10.1038/s41571-019-0203-7
- Bengsch B, Johnson AL, Kurachi M, et al. Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion. Immunity. 2016;45(2):358-373. doi:10.1016/j.immuni.2016.07.008
- Scharping NE, Menk AV, Moreci RS, et al. The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Immunity. 2016;45(2):374-388. doi:10.1016/j.immuni.2016.07.009
- Siska PJ, Beckermann KE, Mason FM, et al. Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight. 2017;2(12):93411. doi:10.1172/jci.insight.93411
This list of references to third-party peer-reviewed material and the sites they are hosted on are provided for your reference and convenience only and do not imply any review or endorsement of the material or any association with their operators. The Third-Party References (and the Web sites to which they link) may contain information that is inaccurate, incomplete, or outdated. Your access and use of the Third Party Sites (and any Web sites to which they link) is solely at your own risk.
© 2023 BD. All rights reserved. Unless otherwise noted, BD, the BD Logo and all other trademarks are the property of Becton, Dickinson and Company or its affiliates.
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.